04/04/2024
3:31 PM | CytomX Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024
3:33 PM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
6:12 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | CytomX Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
3:27 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:36 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:37 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/21/2024
3:38 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:40 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:41 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | CytomX Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/19/2024
7:41 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:43 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:44 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:37 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:38 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:40 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:54 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:55 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:56 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:57 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:58 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:12 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:13 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:15 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:16 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2023
11:15 PM | CytomX Therapeutics (Filer)
| Form EFFECT | |
08/24/2023
3:05 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
8:40 PM | CytomX Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/20/2023
4:17 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/20/2023
4:18 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:06 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:49 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:49 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:50 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:51 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:52 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:54 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
3:52 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
